Marinissen M J, Chiariello M, Pallante M, Gutkind J S
Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892-4330, USA.
Mol Cell Biol. 1999 Jun;19(6):4289-301. doi: 10.1128/MCB.19.6.4289.
The expression of the c-jun proto-oncogene is rapidly induced in response to mitogens acting on a large variety of cell surface receptors. The resulting functional activity of c-Jun proteins appears to be critical for cell proliferation. Recently, we have shown that a large family of G protein-coupled receptors (GPCRs), represented by the m1 muscarinic receptor, can initiate intracellular signaling cascades that result in the activation of mitogen-activated protein kinases (MAPK) and c-Jun NH2-terminal kinases (JNK) and that the activation of JNK but not of MAPK correlated with a remarkable increase in the expression of c-jun mRNA. Subsequently, however, we obtained evidence that GPCRs can potently stimulate the activity of the c-jun promoter through MEF2 transcription factors, which do not act downstream from JNK. In view of these observations, we set out to investigate further the nature of the signaling pathway linking GPCRs to the c-jun promoter. Utilizing NIH 3T3 cells, we found that GPCRs can activate the c-jun promoter in a JNK-independent manner. Additionally, we demonstrated that these GPCRs can elevate the activity of novel members of the MAPK family, including ERK5, p38alpha, p38gamma, and p38delta, and that the activation of certain kinases acting downstream from MEK5 (ERK5) and MKK6 (p38alpha and p38gamma) is necessary to fully activate the c-jun promoter. Moreover, in addition to JNK, ERK5, p38alpha, and p38gamma were found to stimulate the c-jun promoter by acting on distinct responsive elements. Taken together, these results suggest that the pathway linking GPCRs to the c-jun promoter involves the integration of numerous signals transduced by a highly complex network of MAPK, rather than resulting from the stimulation of a single linear protein kinase cascade. Furthermore, our findings suggest that each signaling pathway affects one or more regulatory elements on the c-jun promoter and that the transcriptional response most likely results from the temporal integration of each of these biochemical routes.
c-jun原癌基因的表达会因作用于多种细胞表面受体的促分裂原而迅速被诱导。由此产生的c-Jun蛋白的功能活性似乎对细胞增殖至关重要。最近,我们发现以m1毒蕈碱受体为代表的一大类G蛋白偶联受体(GPCR)能够启动细胞内信号级联反应,导致丝裂原活化蛋白激酶(MAPK)和c-Jun氨基末端激酶(JNK)的激活,并且JNK而非MAPK的激活与c-jun mRNA表达的显著增加相关。然而,随后我们获得的证据表明,GPCR能够通过MEF2转录因子有力地刺激c-jun启动子的活性,而MEF2转录因子并非在JNK的下游起作用。鉴于这些观察结果,我们着手进一步研究将GPCR与c-jun启动子连接起来的信号通路的本质。利用NIH 3T3细胞,我们发现GPCR能够以不依赖JNK的方式激活c-jun启动子。此外,我们证明这些GPCR能够提高MAPK家族新成员的活性,包括ERK5、p38α、p38γ和p38δ,并且MEK5(ERK5)和MKK6(p38α和p38γ)下游某些激酶的激活对于完全激活c-jun启动子是必要的。此外,除了JNK之外,还发现ERK5、p38α和p38γ通过作用于不同的反应元件来刺激c-jun启动子。综上所述,这些结果表明,将GPCR与c-jun启动子连接起来的信号通路涉及由高度复杂的MAPK网络转导的众多信号的整合,而不是由单一的线性蛋白激酶级联反应的刺激所导致。此外,我们的研究结果表明,每条信号通路都会影响c-jun启动子上的一个或多个调控元件,并且转录反应很可能是由这些生化途径中每一条的时间整合所导致的。